Latest profit margin for Imed Infinity Medical-Limited Partnership: -31.13% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Imed Infinity Medical-Limited Partnership posts a profit margin of -31.13% as of June 2026. That compares with 281.9% in the prior-year period — down 111.0% year over year. That is below the sector sector average of 13.4%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, Imed Infinity Medical-Limited Partnership's profit margin was 281.9%. The latest reading is -31.13% — a 111.0% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.
For its sector stocks, a profit margin near 13.4% is typical. Imed Infinity Medical-Limited Partnership's -31.13% is lower that level. That is roughly 332.2% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.
Imed Infinity Medical-Limited Partnership's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -31.13% as of June 2026; use YoY and peer views to separate noise from signal.
Context for IMED.TA's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.4%), and (3) consistency with growth and profitability. This page covers the first two; Imed Infinity Medical-Limited Partnership's other metric pages and overview cover the third.